Kyverna's Phase 2 trial of Miv-Cel meets key endpoints, shares up over 30% pre-market

lunes, 15 de diciembre de 2025, 6:38 am ET1 min de lectura
KYTX--

Kyverna's Phase 2 trial of Miv-Cel meets key endpoints, shares up over 30% pre-market

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios